Received Apr 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | Y000225 | OT / LL |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | 3CA20C1 | OT |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | NIC74IM | OT |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | U8442BA | OT |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Y011019 | OT / LL |
No other information provided. No additional AEs/PQC reported.; vaccines administered after temperature excursion; This spontaneous report was received from a medical assistant and refers to a(n) 4-year-old male patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not provided. On 17-APR-2025, the patient was vaccinated with vaccines that suffered temperature excursion with a temperature - 9.8 C, for a time frame of 2 hours 3 minutes, with digital data logger: dose number 2Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) solution for injection (lot #Y000225, expiration date: 03-JAN-2026), administered by Subcutaneous route in Left Thigh; dose # 2 of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) solution for injection (lot #Y011019, expiration date: 18-JUN-2026), administered by subcutaneous route in Left Thigh, both as prophylaxis (exact doses not reported), reconstituted with sterile diluent. Also received on the same date, Diphtheria vaccine toxoid (+) Pertussis vaccine acellular (+) Tetanus vaccine toxoid (Dtap) (lot #3CA20C1, expiration date: 28-FEB-2026) (Previous doses: 4, administered right thigh), administered by Intramuscular route; Ipv (Polio vaccine inact) (lot #NIC74IM, expiration date: 17-NOV-2025) (Number of previous doses: 3, administered right thigh), administered by Intramuscular route; and Influenza vaccine (Influenza vaccine) (lot #U8442BA, expiration date: 30-JUN-2025) (Number of previous doses: 4, administered Right thigh), administered by Intramuscular route (doses, indications were not reported). No previous temperature excursions were reported. No other information provided. No additional adverse events (AEs)/product quality complaints (PQC) reported.
sterile diluent; sterile diluent